BioNTech Archives | the deep dive

the deep dive

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations to create quality stock analysis for investors. Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

BioNTech

NIH Issues Notice of Default to BioNTech Over Alleged Royalty Payments

New COVID Variant Sweeps China, Is North America Next?

Pfizer-BioNTech Set To Supply The US Government With 105 Million COVID-19 Vaccine For US$3.2 Billion

BioNTech Sees Vaccine Sales Push Q1 Revenues To €6.4 Billion

BioNTech Ends Q3 2021 With €6.1 Billion In Revenue

BioNTech Sent Plummeting Following Damning Whistleblower Report, News of Covid-19 Pills

Pfizer-BioNTech COVID-19 Vaccine Trial For Ages 5-11 Returns Favorable Topline Results

Mergers Set the Stage for Uranium’s Growth Cycle | Forum-Baselode Merger

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

First Majestic Produces 7.9 Silver Equivalent Ounces In Q2, Lifts Production Guidance

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill